Private Equity & Venture Capital - Page 1 | TalkMarkets


All Posts > Content under Private Equity & Venture Capital
1 to 16 of 675 Posts
1 2 3 ... 43 >>>
Week In Review: Hengrui And Degron Announce $7.2 Billion In Drug Licensings
Article By: ChinaBio® Today
Saturday, May 25, 2024 4:00 PM EDT
Jiangsu Hengrui Medicine out-licensed global rights for its portfolio of three proprietary GLP-1 candidates to a US startup, Hercules, in a deal worth up to $6 billion. Hengrui will receive $110 million upfront and up to $200 million in milestones.
In this article: AZN, BGNE, TAK, IVBXF, CSPHF
Ranked: The Top Startup Cities Around The World
Article By: Jeff Desjardins
Tuesday, May 21, 2024 10:24 AM EDT
A richly connected network of founders, venture capital firms, and tech talent are some of the key ingredients driving a startup ecosystem.
Week In Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
Article By: ChinaBio® Today
Sunday, May 19, 2024 7:14 PM EDT
In the headline deal, Takeda acquires global rights from AC Immune of Switzerland for $100 million upfront and up to $2.1B in milestones.
In this article: SLGL, TAK
Week In Review: Sciwind, Sino Biological And Biocytogen Announce Deals
Article By: ChinaBio® Today
Saturday, May 11, 2024 3:40 PM EDT
Beijing’s Sino Biological completed its $48 million acquisition of Vancouver-based SignalChem Biotech. Additionally, Biocytogen Pharmaceuticals signed a TCR-mimic antibody evaluation and potential licensing agreement with BioCopy AG.
In this article: DHR, IVBXF, WUXIF
IPO Nearing? Elon Musk's Starlink In Hyper-Growth, Surprises Analysts With $6.6 Billion Revenue Projection
Article By: Tyler Durden
Saturday, May 11, 2024 1:20 PM EDT
A new report shows SpaceX's Starlink could be closer than ever to an initial public offering. The space internet company's 2024 forecasted revenue will top $6.6 billion. 
EQT Strikes A Deal For Post-Covid Tech Hangover
Article By: Lipper Alpha Insight
Saturday, May 11, 2024 10:39 AM EDT
Dealmakers might be emerging from their bleary post-pandemic technology hangover. If Perficient’s $3 billion sale to buyout shop EQT is any indication, it could be time to pick up the pieces.
In this article: PRFT Also: ACN
In Defense Of Staying Private
Article By: AllAboutAlpha
Tuesday, May 7, 2024 7:05 AM EDT
I’m not a contrarian by nature, but I do enjoy being a devil’s advocate and while reading a recent piece by JP Morgan on the importance of a reinvigorated private equity exit environment, I couldn’t help but come up with an opposing perspective.
What Should VCs Do With Zombie Companies?
Article By: David Teten
Sunday, May 5, 2024 12:26 PM EDT
Inevitably, some of a VC’s portfolio companies will become “zombies”: not dead, but not growing. So what do you do?
Should Billionaires Exist?
Video By: Robert Reich
Thursday, May 2, 2024 7:41 AM EDT
America has driven more than 650 species to extinction. And it should do the same to billionaires.
What The Rise Of Perplexity Represents
Article By: Pete Pachal
Wednesday, May 1, 2024 9:03 AM EDT
Perplexity isn't the next Google, and that's precisely why it's succeeding.
In this article: GOOGL, ADBE
Demystifying Private Equity Valuations
Article By: Russell Investments
Monday, April 29, 2024 3:30 PM EDT
Private markets have long been viewed by institutional investors as a key component of a well-diversified portfolio.
Gains From Energy
Article By: Simon Lack
Sunday, April 28, 2024 6:51 AM EDT
Last week the WSJ published an interesting chart. It was in an article titled America’s Economy Is No. 1. That Means Trouble. The chart shows that US share of global GDP has been increasing for over a decade. We’ve gone from 21% in 2011 to 26%.
Private Equity More Boondoggle Than Brilliance
Article By: Danielle Park, CFA
Friday, April 26, 2024 1:23 PM EDT
The 2022-23 normalization of interest rates began to illuminate the darkness in private debt and equity products, and redemption requests started to be frozen.
Unlocking US Capital: Strategies For Non-US-Listed Businesses
Video By: Edison
Wednesday, April 24, 2024 1:20 PM EDT
Are you a non-US-listed issuer interested in tapping into the US’s vast capital markets? Our expert panel debunks common myths and provides proven, actionable strategies to effectively target the right investors.
On The Private Markets Racetrack, A Fund-Of-Funds May Help You Win
Article By: Russell Investments
Sunday, April 21, 2024 4:25 PM EDT
Adding private markets to your institutional investment portfolio can seem as intimidating and complicated as building a racecar. A fund-of-funds approach is simpler—with the benefits of alts without the hassle.
Understanding Performance Benchmarking
Article By: AllAboutAlpha
Sunday, April 21, 2024 5:59 AM EDT
One of the most vexing questions in private equity is the assessment of investment returns. To extract a meaningful answer regarding its performance, a private equity group must make a number of decisions about methodology and data.
1 to 16 of 675 Posts
1 2 3 ... 43 >>>